financetom
Business
financetom
/
Business
/
Firan Technology Group Fiscal Q2 Adjusted Profit Rise 13% on Higher Sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Firan Technology Group Fiscal Q2 Adjusted Profit Rise 13% on Higher Sales
Jul 10, 2024 2:27 PM

05:10 PM EDT, 07/10/2024 (MT Newswires) -- Firan Technology Group ( FTGFF ) on Wednesday said its fiscal second-quarter adjusted profit rose 13% on higher sales.

The company posted an adjusted profit, excluding most one-time items, of $2.55 million, or $0.11 per share, in the quarter ended May 31, up from $2.26 million, or $0.10, in the year prior quarter.

Revenue rose 14% to $38.8 million from $33.96 million.

"During Q2 2024, the Corporation has continued to invest in technology in existing sites, grow the business organically, and integrate the two acquisitions completed last year. FTG is strategically deploying its capital in ways that will drive increased shareholder returns for the future in both the near term and long term," the company said.

Firan ( FTGFF ) shares closed down $0.04 to $5.92 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Magnite Insider Sold Shares Worth $298,399, According to a Recent SEC Filing
Magnite Insider Sold Shares Worth $298,399, According to a Recent SEC Filing
Jun 14, 2024
04:36 PM EDT, 06/14/2024 (MT Newswires) -- David Day, CFO, on June 12, 2024, sold 21,299 shares in Magnite ( MGNI ) for $298,399. Following the Form 4 filing with the SEC, Day has control over a total of 449,832 shares of the company, with 449,832 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1595974/000141588924016936/xslF345X03/form4-06142024_040626.xml Price: 13.48, Change: -0.25, Percent Change: -1.82 ...
United Therapeutics Insider Sold Shares Worth $1,027,716, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,027,716, According to a Recent SEC Filing
Jun 14, 2024
04:37 PM EDT, 06/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on June 13, 2024, sold 3,600 shares in United Therapeutics ( UTHR ) for $1,027,716. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 647,195 shares of the company, with 130 shares held directly and 647,065 controlled indirectly. SEC Filing:...
AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer
AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer
Jun 14, 2024
04:37 PM EDT, 06/14/2024 (MT Newswires) -- AbbVie ( ABBV ) late Friday recommended shareholders decline from participating in an unsolicited mini-tender offer from Tutanota seeking to buy up to 250,000 of the drug maker's shares at $165 apiece. AbbVie ( ABBV ) said the May 28 tender offer is conditioned on its share price closing above the offer price...
Arcellx Insider Sold Shares Worth $1,102,668, According to a Recent SEC Filing
Arcellx Insider Sold Shares Worth $1,102,668, According to a Recent SEC Filing
Jun 14, 2024
04:36 PM EDT, 06/14/2024 (MT Newswires) -- Christopher Heery, Chief Medical Officer, on June 12, 2024, sold 20,000 shares in Arcellx ( ACLX ) for $1,102,668. Following the Form 4 filing with the SEC, Heery has control over a total of 9,278 shares of the company, with 9,278 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1786205/000141588924016939/xslF345X03/form4-06142024_080657.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved